Indian Journal of Surgery

, Volume 77, Issue 1, pp 49–54 | Cite as

Surgical Trauma and Immune Functional Changes Following Major Lung Resection

Review Article
First Online:
Received:
Accepted:

Abstract

Video-assisted thoracic surgery (VATS) has evolved greatly over the last two decades. VATS major lung resection for early stage non-small cell lung carcinoma (NSCLC) has been shown to result in less postoperative pain, less pulmonary dysfunction postoperatively, shorter hospital stay, and better patient tolerance to adjuvant chemotherapy compared with patients who underwent thoracotomy. Several recent studies have even reported improved long-term survival in those who underwent VATS major lung resection for early stage NSCLC when compared with open technique. Interestingly, the immune status and autologous tumor killing ability of lung cancer patients have previously been associated with long-term survival. VATS major lung resection can result in an attenuated postoperative inflammatory response. Furthermore, the minimal invasive approach better preserve patients’ postoperative immune function, leading to higher circulating natural killer and T cells numbers, T cell oxidative activity, and levels of immunochemokines such as insulin growth factor binding protein 3 following VATS compared with thoracotomy. Apart from host immunity, the angiogenic environment following surgery may also have a role in determining cancer recurrence and possibly survival. Whether differences in immunological and biochemical mediators contribute significantly towards improved clinical outcomes following VATS major lung resection for lung cancer remains to be further investigated. Future studies will also need to address whether the reduced access trauma from advanced thoracic surgical techniques, such as single-port VATS, can further attenuate the postoperative inflammatory response.

Keywords

Angiogenesis Immune Inflammation Single port Trauma Thoracotomy VATS 
This is a preview of subscription content, log in to check access.

Notes

Conflict of Interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

References

  1. 1.
    Gonzalez-Rivas D, Paradela M, Fieira E, Velasco C (2012) Single-incision video-assisted thoracoscopic lobectomy: initial results. J Thorac Cardiovasc Surg 143:745–747CrossRefPubMedGoogle Scholar
  2. 2.
    Shiraishi T, Shirakusa T, Hiratsuka M, Yamamoto S, Iwasaki A (2006) Video-assisted thoracoscopic surgery lobectomy for c-T1N0M0 primary lung cancer: its impact on locoregional control. Ann Thorac Surg 82:1021–1026CrossRefPubMedGoogle Scholar
  3. 3.
    Yim AP (2002) VATS major pulmonary resection revisited—controversies, techniques, and results. Ann Thorac Surg 74:615–623CrossRefPubMedGoogle Scholar
  4. 4.
    Nicastri DG, Wisnivesky JP, Litle VR, Yun J, Chin C, Dembitzer FR, Swanson SJ (2008) Thoracoscopic lobectomy: report on safety, discharge independence, pain, and chemotherapy tolerance. J Thorac Cardiovasc Surg 135:642–647CrossRefPubMedGoogle Scholar
  5. 5.
    Petersen RP, Pham D, Burfeind WR, Hanish SI, Toloza EM, Harpole DH Jr, D’Amico TA (2007) Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer. Ann Thorac Surg 83:1245–1250CrossRefPubMedGoogle Scholar
  6. 6.
    Cajipe MD, Chu D, Bakaeen FG, Casal RF, Lemaire SA, Coselli JS, Cornwell LD (2012) Video-assisted thoracoscopic lobectomy is associated with better perioperative outcomes than open lobectomy in a veteran population. Am J Surg 204:607–612CrossRefPubMedGoogle Scholar
  7. 7.
    Handy JR Jr, Asaph JW, Douville EC, Ott GY, Grunkemeier GL, Wu Y (2010) Does video-assisted thoracoscopic lobectomy for lung cancer provide improved functional outcomes compared with open lobectomy? Eur J Cardiothorac Surg 37:451–455PubMedGoogle Scholar
  8. 8.
    Kaseda S, Aoki T, Hangai N, Shimizu K (2000) Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy. Ann Thorac Surg 70:1644–1646CrossRefPubMedGoogle Scholar
  9. 9.
    Sawada S, Komori E, Yamashita M, Nakata M, Nishmura R, Teramoto N, Segawa Y, Shinkai T (2007) Comparison in prognosis after VATS lobectomy and open lobectomy for stage I lung cancer. Retrospective analysis focused on a histological subgroup. Surg Endosc 21:1607–1611CrossRefPubMedGoogle Scholar
  10. 10.
    Yamashita JI, Kurusu Y, Fujino N, Saisyoji T, Ogawa M (2000) Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg 119:899–905CrossRefPubMedGoogle Scholar
  11. 11.
    Shigemura N, Akashi A, Funaki S, Nakagiri T, Inoue M, Sawabata N, Shiono H, Minami M, Takeuchi Y, Okumura M, Sawa Y (2006) Long-term outcomes after a variety of video-assisted thoracoscopic lobectomy approaches for clinical stage 1A lung cancer: a multi-institutional study. J Thorac Cardiovasc Surg 132:507–512CrossRefPubMedGoogle Scholar
  12. 12.
    Li Y, Wang J (2012) Comparison of clinical outcomes for patients with clinical N0 and pathologic N2 non-small cell lung cancer after thoracoscopic lobectomy and open lobectomy: a retrospective analysis of 76 patients. J Surg Oncol 106:431–435CrossRefPubMedGoogle Scholar
  13. 13.
    Ng CSH, Whelan RL, Lacy AM, Yim APC (2005) Is minimal access surgery for cancer associated with immunologic benefits? World J Surg 29:975–981CrossRefPubMedGoogle Scholar
  14. 14.
    Vittimberga FJ Jr, Foley DP, Meyers WC, Callery MP (1998) Laparoscopic surgery and the systemic immune response. Ann Surg 227:326–334CrossRefPubMedCentralPubMedGoogle Scholar
  15. 15.
    Delgado S, Lacy AM, Filella X, Castells A, Garcia-Valdecasas JC, Pique JM, Momblan D, Visa J (2001) Acute phase response in laparoscopic and open colectomy in colon cancer. Dis Colon Rectum 44:638–664CrossRefPubMedGoogle Scholar
  16. 16.
    Leung KL, Lai PBS, Ho RLK, Meng WCS, Raymond YYC, Lee JFY, Lau WY (2000) Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: a prospective randomized trial. Ann Surg 231:506–511CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Craig SR, Leaver HA, Yap PL, Pugh GC, Walker WS (2001) Acute phase responses following minimal access and conventional thoracic surgery. Eur J Cardiothorac Surg 20:455–463CrossRefPubMedGoogle Scholar
  18. 18.
    Yim APC, Wan S, Lee TW, Arifi AA (2000) VATS lobectomy reduces cytokine responses compared with conventional surgery. Ann Thorac Surg 70:243–247CrossRefPubMedGoogle Scholar
  19. 19.
    Nagahiro I, Andou A, Aoe M, Sano Y, Date H, Shimizu N (2001) Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure. Ann Thorac Surg 72:362–365CrossRefPubMedGoogle Scholar
  20. 20.
    Ito Y, Oda M, Tsunezuka Y, Matsumoto I, Ishikawa N, Kawakami K, Ota Y, Watanabe G (2009) Reduced perioperative immune response in video-assisted versus open surgery in a rat model. Surg Today 39:682–688CrossRefPubMedGoogle Scholar
  21. 21.
    Szczęsny TJ, Słotwiński R, Szczygieł B, Stankiewicz A, Zaleska M, Kopacz M, Olesińska-Grodź A (2007) Systematic mediastinal lymphadenectomy does not increase postoperative immune response after major lung resections. Eur J Cardiothorac Surg 32:868–872CrossRefPubMedGoogle Scholar
  22. 22.
    Tsuruma T, Yagihashi A, Torigoe T, Sato N, Kikuchi K, Watanabe N, Hirata K (1998) Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras-transformed cells. Cell Immunol 184:121–128CrossRefPubMedGoogle Scholar
  23. 23.
    Ng CSH, Lee TW, Wan S et al (2005) Thoracotomy is associated with significantly more profound suppression in lymphocytes and natural killer cells than video-assisted thoracic surgery following major lung resections for cancer. J Invest Surg 18:81–88CrossRefPubMedGoogle Scholar
  24. 24.
    Chang KT, Tsai CM, Chiou YC, Chiu CH, Jeng KS, Huang CY (2005) IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells. Am J Physiol Lung Cell Mol Physiol 289:L446–L453CrossRefPubMedGoogle Scholar
  25. 25.
    Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D (2002) Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 62:1030–1035PubMedGoogle Scholar
  26. 26.
    Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY, Gong K (2002) Clinical significance of IGFBP-3 expression in stage I non-small cell lung cancer. Clin Cancer Res 8:3796–3802PubMedGoogle Scholar
  27. 27.
    Kirman I, Poltoratskaia N, Sylla P, Whelan RL (2004) Insulin-like growth factor-binding protein 3 inhibits growth of experimental colocarcinoma. Surgery 136:205CrossRefPubMedGoogle Scholar
  28. 28.
    Ng CSH, Wan S, Hui CWC, Wan IYP, Lee TW, Underwood MJ, Yim APC (2007) Video-assisted thoracic surgery lobectomy for lung cancer is associated with less immunochemokine disturbances than thoracotomy. Eur J Cardiothorac Surg 31:83–87CrossRefPubMedGoogle Scholar
  29. 29.
    Belizon A, Kirman I, Balik E, Karten M, Jain S, Whelan RL (2007) Major surgical trauma induces proteolysis of insulin-like growth factor binding protein-3 in transgenic mice and is associated with a rapid increase in circulating levels of matrix metalloproteinase-9. Surg Endosc 21:653–658CrossRefPubMedGoogle Scholar
  30. 30.
    Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67–68CrossRefPubMedGoogle Scholar
  31. 31.
    Iizasa T, Fujisawa T, Suzuki M, Motohashi S, Yasufuku K, Yasukawa T, Baba M, Shiba M (1999) Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients. Clin Cancer Res 5:149–153PubMedGoogle Scholar
  32. 32.
    Brune IB, Wilke W, Hensler T, Holzmann B, Siewert J-R (1999) Downregulation of T helper type 1 immune response and altered proinflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery. Am J Surg 177:55–60CrossRefPubMedGoogle Scholar
  33. 33.
    Decker D, Schondorf M, Bidlingmaier F, Hirner A, von Ruecker AA (1996) Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down regulation of cell mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 119:316–325CrossRefPubMedGoogle Scholar
  34. 34.
    Leaver HA, Craig SR, Yap PL, Walker WS (2000) Lymphocyte responses following open and minimally invasive thoracic surgery. Eur J Clin Invest 30:230–238CrossRefPubMedGoogle Scholar
  35. 35.
    Inoue H, Ishihara T, Kobayashi K, Fukai S (1978) Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis. J Thorac Cardiovasc Surg 76:479–482PubMedGoogle Scholar
  36. 36.
    Cannon GB, Dean JH, Herberman RB, Perlin E, Reid J, Miller C, Lang NP (1980) Association of depressed postoperative lymphoproliferative responses to alloantigens with poor prognosis in patients with stage I lung cancer. Int J Cancer 25:9–17CrossRefPubMedGoogle Scholar
  37. 37.
    Uchida A, Kariya Y, Okamoto N, Sugie K, Fujimoto T, Yagita M (1990) Prediction of postoperative clinical course by autologous tumor-killing activity in lung cancer patients. J Natl Cancer Inst 82:1697–1701CrossRefPubMedGoogle Scholar
  38. 38.
    Fujisawa T, Yamaguchi Y (1997) Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung. Cancer 79:474–481CrossRefPubMedGoogle Scholar
  39. 39.
    Nakamura H, Saji H, Ogata A, Hosaka M, Hagiwara M, Kawasaki N, Konaka C, Kato H (2002) Immunologic parameters as significant prognostic factors in lung cancer. Lung Cancer 37:161–169CrossRefPubMedGoogle Scholar
  40. 40.
    Nakamura H, Idiris A, Kato Y, Kato H (2004) An increase in the percentage of HLA-DR-positive peripheral leukocytes predicts a poor prognosis in patients with squamous cell carcinoma of the lung. Oncol Rep 11:673–676PubMedGoogle Scholar
  41. 41.
    Ito N, Suzuki Y, Taniguchi Y, Ishiguro K, Nakamura H, Ohgi S (2005) Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer. Anticancer Res 25:2027–2031PubMedGoogle Scholar
  42. 42.
    Sperduto P, Vaezy A, Bridgman A, Wilkie L (1988) Spontaneous regression of squamous cell lung carcinoma with adrenal metastasis. Chest 94:887–889CrossRefPubMedGoogle Scholar
  43. 43.
    Darnell BR, Deangelis ML (1993) Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 341:21–22CrossRefPubMedGoogle Scholar
  44. 44.
    Langrish CL, McKenzie BS, Wilson NJ, de Waal MR, Kastelein RA, Cua DJ (2004) IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 202:96–105CrossRefPubMedGoogle Scholar
  45. 45.
    Trinchieri G (1994) Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008–4027PubMedGoogle Scholar
  46. 46.
    Benatar T, Cao MY, Lee Y, Li H, Feng N, Gu X, Lee V, Jin H, Wang M, Der S, Lightfoot J, Wright JA, Young AH (2008) Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors. Cancer Immunol Immunother. 57(12):1757–1769Google Scholar
  47. 47.
    Belizon A, Balik E, Horst P, Feingold D, Arnell T, Azarani T, Cekic V, Skitt R, Kumara S, Whelan RL (2008) Persistent elevation of plasma vascular endothelial growth factor levels during the first month after minimally invasive colorectal resection. Surg Endosc 22:287–297CrossRefPubMedGoogle Scholar
  48. 48.
    Belizon A, Balik E, Feingold DL, Bessler M, Arnell TD, Forde KA, Horst PK, Jain S, Cekic V, Kirman I, Whelan RL (2006) Major abdominal surgery increases plasma levels of vascular endothelial growth factor—open more so than minimally invasive methods. Ann Surg 244:792–798CrossRefPubMedCentralPubMedGoogle Scholar
  49. 49.
    Ng CSH, Wan S, Wong RHL, Ho AMH, Yim APC (2012) Angiogenic response to major lung resection for non-small cell lung cancer with video-assisted thoracic surgical and open access. Scientific World Journal 2012:636754PubMedCentralPubMedGoogle Scholar
  50. 50.
    Beilin B, Shavit Y, Trabekin E, Mordashev B, Mayburd E, Zeidel A, Bessler H (2003) The effects of postoperative pain management on immune response to surgery. Anesth Analg 97:822–827CrossRefPubMedGoogle Scholar
  51. 51.
    Shigemura N, Hsin MK, Yim AP (2006) Segmental rib resection for difficult cases of video-assisted thoracic surgery. J Thorac Cardiovasc Surg 132:701–702CrossRefPubMedGoogle Scholar
  52. 52.
    Ng CSH, Lau KKW, Wong RHL, Lau RWH, Kwok MWT, Wan IYP, Wan S, Underwood MJ (2013) Single port video-assisted thoracoscopic lobectomy for early stage non-small cell lung carcinoma. Surg Pract 17:35–36CrossRefGoogle Scholar
  53. 53.
    Ng CSH, Lau KKW, Gonzalez-Rivas D, Rocco G (2013) Evolution in surgical approach and techniques for lung cancer. Thorax 68:681. doi: 10.1136/thoraxjnl-2012-203157 CrossRefPubMedGoogle Scholar

Copyright information

© Association of Surgeons of India 2013

Authors and Affiliations

  1. 1.Division of Cardiothoracic Surgery, Prince of Wales HospitalThe Chinese University of Hong KongHong KongChina
  2. 2.Department of Cardiothoracic SurgerySt Bartholomew’s HospitalLondonUK

Personalised recommendations